Across TCGA pan-cancer cohorts, ZNF702P Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ZNF702P data layer compared with 21 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ZNF702P Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated ZNF702P expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.
UCEC, LUAD, and LIHC are the cancer types where ZNF702P Mutation most reproducibly stratifies survival.